Mylan Failed To Prove Identical Ingredients: Abbott Suit
Illinois-based Abbott sued West Virginia-based Mylan in response to Mylan’s amended Abbreviated New Drug Application filed with the U.S. Food and Drug Administration in October. The suit was filed in U.S. District Court for the Northern District of Illinois.
Abbott’s two Depakote patents, both...
To view the full article, register now.